Newlink Genetics reported $5.24M in Current Liabilities for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Agenus AGEN:US $ 159.72M 3.34M
Bristol Myers Squibb BMY:US $ 20915M 1906M
Celldex Therapeutics CLDX:US $ 29.95M 15.39M
Eli Lilly And LLY:US $ 15620.6M 2234.6M
Idera Pharmaceuticals IDRA:US $ 4.74M 0.94M
Intrexon XON:US $ 29.9M 4.3M
Nektar Therapeutics NKTR:US $ 104.98M 0.3M
Newlink Genetics NLNK:US $ 5.24M 0.11M
Prothena PRTA:US 40.11M 3.61M
Sarepta Therapeutics SRPT:US $ 545.57M 90.6M
Vascular Biogenics VBLT:US 11.05M 1.12M
YTE INCY:US $ 926.67M 40.51M